Stock Analysis

Lifecare Third Quarter 2024 Earnings: kr1.07 loss per share (vs kr0.78 loss in 3Q 2023)

OB:LIFE
Source: Shutterstock

Lifecare (OB:LIFE) Third Quarter 2024 Results

Key Financial Results

  • Net loss: kr15.1m (loss widened by 114% from 3Q 2023).
  • kr1.07 loss per share (further deteriorated from kr0.78 loss in 3Q 2023).
earnings-and-revenue-growth
OB:LIFE Earnings and Revenue Growth November 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Lifecare Earnings Insights

Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Medical Equipment industry in Europe.

Performance of the market in Norway.

The company's shares are down 8.6% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 6 warning signs for Lifecare (2 are a bit concerning!) that you need to be mindful of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.